Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
Instituto Valenciano de Oncologia
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (8)
2024
-
Very accelerated partial breast irradiation in 1 or 2 days: Late toxicity and early oncological outcome of the GEC-ESTRO VAPBI cohort
Radiotherapy and Oncology, Vol. 194
2020
-
A retrospective, multicenter study of the efficacy of lapatinib plus trastuzumab in HER2-positive metastatic breast cancer patients previously treated with trastuzumab, lapatinib, or both: the Trastyvere study
Clinical and Translational Oncology, Vol. 22, Núm. 3, pp. 420-428
-
GEICAM Guidelines for the Management of Patients with Breast Cancer During the COVID-19 Pandemic in Spain
Oncologist, Vol. 25, Núm. 9, pp. e1339-e1345
-
Palbociclib combined with endocrine therapy in heavily pretreated HR+/HER2- advanced breast cancer patients: Results from the compassionate use program in Spain (PALBOCOMP)
Breast, Vol. 54, pp. 286-292
2018
-
Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey
European Journal of Surgical Oncology, Vol. 44, Núm. 2, pp. 228-236
2013
-
Intraoperative molecular analysis of total tumor load in sentinel lymph node: A new predictor of axillary status in early breast cancer patients
Breast Cancer Research and Treatment, Vol. 139, Núm. 1, pp. 87-93